Turnstone Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.69	28.93	17.8	34.73	123.38
Short-Term Investments	-	-	76.98	47.33	37.64
Cash & Short-Term Investments	16.69	28.93	94.78	82.06	161.02
Cash Growth	-73.26%	-69.48%	15.50%	-49.04%	-
Receivables	-	-	0.19	8.73	6.72
Prepaid Expenses	0.37	3.19	4.66	5.08	9.23
Restricted Cash	1.91	0.12	0.12	0.38	0.38
Other Current Assets	2.15	1.99	2.81	1.75	-
Total Current Assets	21.11	34.22	102.55	98	177.34
Property, Plant & Equipment	-	5.11	9.12	14.36	9.37
Other Long-Term Assets	-	0.81	1.14	2.58	0.54
Total Assets	21.11	40.14	112.82	114.94	187.24
Accounts Payable	2.69	0.87	0.04	3.44	0.03
Accrued Expenses	3.25	6.24	9.91	10.22	14.03
Current Portion of Leases	0.41	1.09	2.03	1.96	0.66
Current Income Taxes Payable	-	-	-	-	0.25
Current Unearned Revenue	-	-	-	15.14	33.03
Other Current Liabilities	-	-	-	4.06	6.97
Total Current Liabilities	6.35	8.2	11.97	34.83	54.98
Long-Term Leases	-	0.1	1.19	3.21	2.02
Long-Term Unearned Revenue	-	-	-	4.16	39.37
Other Long-Term Liabilities	-	0.37	0.99	2.27	0.97
Total Liabilities	6.35	8.67	14.15	44.46	97.34
Common Stock	0.02	0.02	0.02	0	0.02
Additional Paid-In Capital	279.83	279.24	275.52	20.5	9.1
Retained Earnings	-264.89	-247.6	-176.76	-121.56	-90.72
Comprehensive Income & Other	-0.2	-0.2	-0.12	-0.41	-0.25
Total Common Equity	14.76	31.47	98.67	-101.47	-81.85
Shareholders' Equity	14.76	31.47	98.67	70.48	89.9
Total Liabilities & Equity	21.11	40.14	112.82	114.94	187.24
Total Debt	0.41	1.19	3.21	5.17	2.68
Net Cash (Debt)	16.28	27.74	91.56	76.9	158.34
Net Cash Growth	-72.96%	-69.71%	19.07%	-51.44%	-
Net Cash Per Share	0.70	1.20	7.92	30.95	58.65
Filing Date Shares Outstanding	23.14	23.14	23.1	3.03	2.15
Total Common Shares Outstanding	23.14	23.14	23.1	2.92	2.15
Working Capital	14.76	26.02	90.58	63.17	122.37
Book Value Per Share	0.64	1.36	4.27	-34.80	-38.08
Tangible Book Value	14.76	31.47	98.67	-101.47	-81.85
Tangible Book Value Per Share	0.64	1.36	4.27	-34.80	-38.08
Machinery	-	10.74	11.73	14.04	5.93
Construction In Progress	-	-	-	-	2.94
Leasehold Improvements	-	1.31	1.31	1.31	1.31

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q